York Space Systems Cuts FY26 Revenue Guidance to $375M-$405M Despite Q2 Revenue Growth
YSS is trading near its 52-week low of $10.005 (9.6% below the low) on elevated volume (1.9× avg).
Summary
York Space Systems reported Q2 revenue up 10% to $92.5 million but cut full-year 2026 revenue guidance to $375M-$405M due to slower government contract awards. Net loss widened to $39.3 million, and backlog fell 8% sequentially to $592 million.
Key Events · Earnings and Guidance · YSS
-
FY26 Revenue Guidance Cut
Full-year 2026 revenue guidance lowered to $375 million to $405 million, down from prior expectations, due to a shift in government acquisition methods toward IDIQ contracts that are slower to start.
-
Q2 Revenue Up 10%
Q2 2026 revenue was $92.5 million, up 10% year-over-year, driven by growth in major government programs. Gross margin improved to 24% from 11%.
-
Net Loss Widens
Q2 net loss was $39.3 million, up 62% from $24.2 million a year ago, driven by $10.9 million in stock compensation expense and $6.0 million in transaction costs.
-
Backlog Declines 8%
Backlog stood at $592.0 million as of June 30, 2026, down 8% from $642.3 million on March 31, 2026, but up 9% from the start of the year.
Analysis · YSS · Manufacturing
York Space Systems reported Q2 revenue of $92.5 million, up 10% year-over-year, but slashed its full-year 2026 revenue guidance to $375 million to $405 million, citing a shift in government acquisition methods toward IDIQ contracts that are slower to start. The company's net loss widened to $39.3 million for the quarter, driven by $10.9 million in stock compensation and $6.0 million in transaction costs. Backlog declined 8% sequentially to $592 million, though the company highlighted an $11.5 billion pipeline and strong liquidity of $684 million. The guidance cut is the key negative, but the company's cash position and contract win rate provide some offset.
At the time of this filing, YSS was trading at $9.04 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $10.01 to $44.54. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.